(Q42806301)

7 November 2017

title

Prediction of in vitro response to interferon-alpha in renal cell carcinoma cell lines (English)

1 reference

7 November 2017

0 references

1 reference

Toru Shimazui

1

1 reference

7 November 2017

Yoshihiro Ami

2

1 reference

7 November 2017

Kazuhiro Yoshikawa

3

1 reference

7 November 2017

Kazuhiko Uchida

4

1 reference

7 November 2017

Takahiro Kojima

5

1 reference

7 November 2017

Takehiro Oikawa

6

1 reference

7 November 2017

Kogenta Nakamura

7

1 reference

7 November 2017

Nobuaki Honda

8

1 reference

7 November 2017

Shiro Hinotsu

9

1 reference

7 November 2017

Jun Miyazaki

10

1 reference

7 November 2017

Noriko Kunita

11

1 reference

7 November 2017

Hideyuki Akaza

12

1 reference

7 November 2017

publication date

31 January 2007

1 reference

7 November 2017

1 reference

7 November 2017

volume

98

1 reference

7 November 2017

issue

4

1 reference

7 November 2017

page(s)

529-534

1 reference

describes a project that uses

7 November 2017

0 references

0 references

0 references

0 references

Mechanisms of hypertension associated with BAY 43-9006.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

Side effects of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

Converting tissue type plasminogen activator into a zymogen. Important role of Lys156.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood m

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

Characterization of the antitumor activities of IFN-alpha8 on renal cell carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

High density lipoprotein-mediated cholesterol uptake and targeting to lipid droplets in intact L-cell fibroblasts. A single- and multiphoton fluorescence approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

Mitogen-inducible gene 6 (MIG-6), adipophilin and tuftelin are inducible by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00421.X

10.1111/J.1349-7006.2007.00421.X

21 January 2018

Identifiers

DOI

1 reference

7 November 2017

1 reference